Published on 29 Nov 2021 on Zacks via Yahoo Finance
Globus Medical, Inc. GMED is gaining from strength in the Enabling Technologies arm. The company exited the third quarter with better-than-expected earnings. The robust performance by ExcelsiusGPS platforms buoys optimism. A strong solvency position is an added advantage. However, escalating expenses and foreign exchange woes raise apprehension.
Over the past year, this Zacks Rank #3 (Hold) stock has gained 6.4% compared with 8.9% growth of the industry and 27.5% rise of the S&P 500 composite.
The renowned medical device company has a market capitalization of $6.49 billion. Its earnings for the third-quarter 2021 surpassed the Zacks Consensus Estimate by 11.1%.